{"organizations": [], "uuid": "3a8c1884bdad01c479e19d1600c5923185e71884", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-savara-initiates-phase-2a-clinical/brief-savara-initiates-phase-2a-clinical-study-of-molgradex-for-the-treatment-of-ntm-lung-infection-idUSFWN1QV0IR", "country": "US", "domain_rank": 408, "title": "BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T14:02:00.000+02:00", "replies_count": 0, "uuid": "3a8c1884bdad01c479e19d1600c5923185e71884"}, "author": "", "url": "https://www.reuters.com/article/brief-savara-initiates-phase-2a-clinical/brief-savara-initiates-phase-2a-clinical-study-of-molgradex-for-the-treatment-of-ntm-lung-infection-idUSFWN1QV0IR", "ord_in_thread": 0, "title": "BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "treatment of ntm lung infection", "sentiment": "negative"}, {"name": "savara inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "treatment of ntm lung infection reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 03 PM / Updated 12 minutes ago BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection Reuters Staff 1 Min Read March 13 (Reuters) - Savara Inc: * SAVARA INITIATES PHASE 2A CLINICAL STUDY OF MOLGRADEX FOR THE TREATMENT OF NTM LUNG INFECTION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-13T14:02:00.000+02:00", "crawled": "2018-03-13T14:22:53.086+02:00", "highlightTitle": ""}